The clinical relevance of TMBIM1 in pancreatic cancer is underscored by our survival analysis of both the TCGA and FUSCC cohorts, where high TMBIM1 expression was significantly associated with poor OS and PFS. The gene discussed is TMBIM1; the disease is pancreatic neoplasm.